Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies

被引：0
|
作者：
Wei-qun Xu
Ling-yan Zhang
Xue-ying Chen
Bin-hua Pan
Jun-qing Mao
Hua Song
Jing-yuang Li
Yong-min Tang
机构：
[1] Children’s Hospital of Zhejiang University,Division of Hematology
[2] School of Medicine,Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
High-dose methotrexate; Elimination delay; Acute lymphoblastic leukemia; Childhood; Non-Hodgkin lymphoma; Creatinine clearance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：79 / 86
页数：7
相关论文
共 50 条
  • [1] Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies
    Xu, Wei-qun
    Zhang, Ling-yan
    Chen, Xue-ying
    Pan, Bin-hua
    Mao, Jun-qing
    Song, Hua
    Li, Jing-yuang
    Tang, Yong-min
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 79 - 86
  • [2] High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: Lack of relation between serum methotrexate concentration and creatinine clearance
    Joannon, P
    Oviedo, I
    Campbell, M
    Tordecilla, J
    PEDIATRIC BLOOD & CANCER, 2004, 43 (01) : 17 - 22
  • [3] Creatinine clearance rate and serum creatinine concentration are related to delayed methotrexate elimination in children with lymphoblastic malignancies
    Mao, J.
    Zhang, L.
    Shen, H.
    Tang, Y.
    Song, H.
    Zhao, F.
    Xu, W.
    NEOPLASMA, 2014, 61 (01) : 77 - 82
  • [4] Serum Creatinine Versus Plasma Methotrexate Levels to Predict Toxicities in Children Receiving High-dose Methotrexate
    Tiwari, Priya
    Thomas, M. K.
    Pathania, Subha
    Dhawan, Deepa
    Gupta, Y. K.
    Vishnubhatla, Sreenivas
    Bakhshi, Sameer
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2015, 32 (08) : 576 - 584
  • [5] The effect of the plasma methotrexate concentration during high-dose methotrexate therapy in childhood acute lymphoblastic leukemia
    Liao, Chan
    Nie, Jing
    Xu, Xiao-Jun
    Zhang, Jing-Ying
    Xu, Wei-Qun
    Song, Hua
    Shen, He-Ping
    Shen, Di-Ying
    Zhao, Fen-Ying
    Liang, Juan
    Miao, Jing
    Tang, Yong-Min
    LEUKEMIA & LYMPHOMA, 2024, 65 (01) : 91 - 99
  • [6] Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma
    Takaaki Nakano
    Ryoji Kobayashi
    Satoru Matsushima
    Daiki Hori
    Masato Yanagi
    Daisuke Suzuki
    Kunihiko Kobayashi
    International Journal of Hematology, 2021, 113 : 744 - 750
  • [7] Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma
    Nakano, Takaaki
    Kobayashi, Ryoji
    Matsushima, Satoru
    Hori, Daiki
    Yanagi, Masato
    Suzuki, Daisuke
    Kobayashi, Kunihiko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (05) : 744 - 750
  • [8] Statistical Analysis of Relation Between Plasma Methotrexate Concentration and Toxicity in High-Dose Methotrexate Therapy of Childhood NonHodgkin Lymphoma
    Tsurusawa, Masahito
    Gosho, Masahiko
    Mori, Tetsuya
    Mitsui, Tetsuo
    Sunami, Shosuke
    Kobayashi, Ryoji
    Fukano, Reiji
    Tanaka, Fumiko
    Fujita, Naoto
    Inada, Hiroko
    Koh, Katsuyoshi
    Takimoto, Tetsuya
    Saito, Akiko
    Fujimoto, Junichiro
    Nakazawa, Atsuko
    Horibe, Keizo
    PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 279 - 284
  • [9] Retrospective study on elimination delay of methotrexate in high-dose therapy of childhood acute lymphoblastic leukemia in China
    Xu, Weiqun
    Tang, Yongmin
    Song, Hua
    Shi, Shuwen
    Yang, Shilong
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (10) : 688 - 693
  • [10] Effects of sodium in hydration solution on plasma methotrexate concentrations following high-dose methotrexate in children with acute lymphoblastic leukemia
    Kinoshita, A
    Kurosawa, Y
    Kondoh, K
    Suzuki, T
    Manabe, A
    Inukai, T
    Sugita, K
    Nakazawa, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (03) : 256 - 260
12345